The role of trace elements in uraemic toxicity

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 2, 2002, Pages 2-8

  Vanholder, Raymond ^a   Cornelis, Rita ^a   Dhondt, Annemieke ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Accumulation; Bone; Depletion; Toxicity; Trace elements; Uraemia

Indexed keywords

ALUMINUM; ARSENIC; CADMIUM; CHROMIUM; COPPER; GERMANIUM; INORGANIC COMPOUND; IRON; LANTHANUM; LEAD; MERCURY; ORGANIC COMPOUND; STRONTIUM; TRACE ELEMENT; UREMIC TOXIN; ZINC;

ANEMIA; ARTICLE; BONE DISEASE; BONE MINERALIZATION; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSATE; DISEASE ASSOCIATION; DRUG CONTAMINATION; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; METABOLIC BONE DISEASE; NONHUMAN; OSTEOMALACIA; PRIORITY JOURNAL; RAT; RENAL OSTEODYSTROPHY; SOLUTE; UREMIA;

EID: 0036230652     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_2.2     Document Type: Article

References (55)

1. Trace element metabolism in renal disease
2. The dialysis encephalopathy syndrome. Possible aluminum intoxication
3. Behaviour of 12 trace elements in serum of uremic patients on hemodiafiltration
4. Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls
5. Trace element concentrations in hair, fingernails and plasma of patients with chronic renal failure on hemodialysis and hemofiltration
6. Comparison of trace elements in peritoneal dialysis, hemodialysis, and uremia
7. Chemical speciation of arsenic in serum of uraemic patients
8. More than tenfold increase of arsenic in serum and packed cells of chronic hemodialysis patients
9. Trace elements in serum, packed cells and dialysate of CAPD patients
10. Disturbances of trace element concentrations in plasma of patients with chronic renal failure
11. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients
12. Serum vanadium levels in chronic hemodialysis patients
13. Arsenic ingestion and internal cancers: A review
14. The influence of the blood levels of lead, aluminum and vanadium upon the arterial hypertension
15. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels
16. Cadmium-induced liver, heart and spleen lipid peroxidation in rats and protection by selenium
17. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
18. Cardiovascular disease from copper deficiency--a history
19. In vitro inhibition of Na-K-ATPase by trace metals: Relation to renal and cardiovascular damage
20. Renal toxicity and arterial hypertension in rats chronically exposed to vanadate
21. Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Time-course of glutathione peroxidase repletion and lipid peroxidation decrease
22. Cobalt but not hypoxia stimulates PDGF gene expression in rats
23. The role of trace elements in uremic heart failure
24. Increased arsenic concentration in the bone marrow in chronic renal failure--a contributor to anaemia?
25. The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: Case report of clinical characteristics and response to treatment
26. Lipofuscin products, lipid peroxides and aluminum accumulation in red blood cells of hemodialyzed patients
27. Anemia and neutropenia due to copper deficiency in enteral nutrition
28. Copper deficiency with pancytopenia during total parenteral nutrition
29. Arsenic intoxication associated with tubulointerstitial nephritis
30. Mechanisms of kidney cell injury from metals
31. Impairment of renal function with increasing blood lead concentrations in the general population
32. Tubulointerstitial nephropathy persisting 20 months after discontinuation of chronic intake of germanium lactate citrate
33. Increased bone strontium levels in hemodialysis patients with osteomalacia
34. Clinical and histologic features of iron-related bone disease in dialysis patients
35. Effects of aluminum on the parathyroid hormone receptors of bone and kidney
36. Cadmium-induced osteomalacic and osteopetrotic lesions in ovariectomized rats
37. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients
38. An assessment of the effects of lanthanum on bone in a chronic renal failure (CRF) rat model
39. Results of a randomized dose-ranging, placebo controlled study of lanthanum carbonate for reduction of serum phosphate in chronic renal failure patients receiving hemodialysis
40. Iron overload and bone disease in chronic dialysis patients
41. Factors determining glucose tolerance in patients with thalassemia major
42. Uremic encephalopathies: Clinical, biochemical, and experimental features
43. Zinc supplementation stimulates tetanus antibody formation and soluble interleukin-2 receptor levels in chronic hemodialysis patients
44. Selenium in uremia
45. Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study
46. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients
47. Copper-related blood indexes in kidney dialysis patients
48. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure
49. Determination of total arsenic in serum and packed cells of patients with renal insufficiency
50. 74As-labeled arsenate in rabbits
51. Accumulation of arsenic species in serum of patients with chronic renal disease
52. 74As-arsenate metabolism in Flemish Giant rabbits with renal insufficiency
53. 74As-arsenate metabolism of Flemish Giant rabbits
54. p-Cresol, a uremic compound, enhances the uptake of aluminum in hepatocytes
55. In vitro methylation of arsenite by rabbit liver cytosol: Effect of metal ions, metal chelating agents, methyltransferase inhibitors and uremic toxins